Pharma & Biotech

At the intersection of computational chemistry and modern drug discovery, Schrodinger operates with a business model that has captured investor...

The coming months represent a pivotal period for biopharmaceutical firm Axsome Therapeutics. As the company strategically expands its commercial capabilities,...

Following the release of its 2025 annual results, Protara Therapeutics has shifted investor attention squarely to its clinical pipeline. The...

Gossamer Bio is navigating a significant challenge following disappointing late-stage trial results for its lead drug candidate, Seralutinib. The biopharmaceutical...

A significant earnings beat and promising clinical developments have prompted a wave of analyst upgrades for Q32 Bio, signaling a...

Investors have delivered a harsh verdict on Evotec SE's latest strategic update. The Hamburg-based biotechnology services firm saw its equity...

The stock of biotechnology firm Ocugen has experienced a significant rally, propelled by a combination of promising clinical developments for...

Pharmaceutical leader Eli Lilly continues to solidify its position in the weight-loss medication sector. The company is benefiting from a...

Investors in Spero Therapeutics are closely monitoring the coming weeks, which could prove pivotal for the company’s fight against multidrug-resistant...

A notable shift is occurring within the shareholder base of medical technology firm Fractyl Health. Specialized investment firms are accumulating...